Form 4: Progyny CFO Sells Shares Under 10b5-1 Plan

Progyny's Chief Financial Officer, Mark S. Livingston, reported transactions involving the sale of company stock, including shares withheld for tax payments and shares sold under a pre-arranged trading plan.

Summary

• Mark S. Livingston, Chief Financial Officer of Progyny, Inc., reported transactions on June 2, 2026.
• 158 shares of common stock were acquired and immediately disposed of, with the disposal representing shares withheld for payment of withholding taxes upon the vesting of restricted stock units.
• An additional 279 shares of common stock were sold.
• These sales were executed under a Rule 10b5-1 trading plan established on August 15, 2025.
• Following these transactions, Mr. Livingston beneficially owns 78,626 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it reports routine insider transactions under a pre-established plan, without indicating significant positive or negative developments for the company.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings, such as this one from Progyny's CFO, are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan is a common strategy for executives to sell shares in a pre-determined manner, mitigating concerns about insider trading.

Stakeholder Impact

• Shareholders: The sale of shares by an executive may be perceived by some shareholders as a negative signal, although the use of a 10b5-1 plan suggests a pre-planned strategy rather than a reaction to adverse company news.

Key Dates

Keywords

Progyny, PGNY, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Executive Compensation, Securities Transaction